CPH
Director Trades
| Date | Director | Value |
|---|
Company News
Creso Pharma’s Halucenex expands phase II psilocybin trial to include non-veteran PTSD sufferers
Creso Pharma’s (ASX: CPH) Canadian acquisition target Halucenex Life Sciences has expanded the recruitment of a phase II clinical trial of psychedelic psilocybin to include non-veteran sufferers of treatment-resistant post-traumatic stress disorder (PTSD). The trial was originally designed to test the efficacy of psilocybin (the active ingredient in magic mushrooms) on veterans and first responders […]
Creso Pharma expands distribution agreement with Route 2 Pharm, eyes Latin American cannabis market
Creso Pharma (ASX: CPH) has expanded a distribution agreement with Route 2 Pharm Pvt Ltd that will see Creso’s hemp-based products sold in Ecuador as a starting point into the lucrative Latin American cannabis market. The deal follows an initial agreement secured in February for Route 2 to import, market, distribute and sell Creso’s cannaQIX […]
Creso Pharma and Halucenex expedite US market entry following proposed law to decriminalise psychedelic drugs
A proposed bill to decriminalise the possession and sharing of psychedelic drugs in California has seen Creso Pharma (ASX: CPH) and its acquisition target Halucenex expedite a market entry strategy for psilocybin compounds as an alternative treatment route for debilitating mental health conditions. Bill 519 was passed by the California state senate overnight and will […]
Creso Pharma’s Canadian subsidiary Halucenex embarks on US market entry strategy
Creso Pharma’s (ASX: CPH) soon-to-be-subsidiary Halucenex Life Sciences Inc has inked a deal with US-based scientific consultancy HeteroGeneity LLC to progress a US market entry strategy for its range of botanical psilocybin products and compounds. Under the terms of the agreement, the companies will conduct a technology assessment to progress a US market development plan for […]
Creso Pharma finalises development of hemp-based feedstock to reduce tail biting in pig herds
Biotechnology company Creso Pharma (ASX: CPH) has finalised the development of a hemp-derived feedstock known as Anibidoil Swine to support stress reduction and wellbeing in pigs. The Swiss-made flour and oat bran product has been designed to lower pig discomfort and reduce the occurrence of tail biting – a common problem in pig herds which […]
Creso Pharma subsidiary Mernova granted craft designation for Ritual Green cannabis products
Creso Pharma’s (ASX: CPH) Canadian subsidiary Mernova Medicinal Inc has been awarded craft designation by the Ontario Cannabis Store (OCS) for its Ritual Green cannabis products. Ritual Green is a small batch producer based in Nova Scotia with approximately 30 employees who tend to each plant and bud to deliver a premium quality that the […]
Creso Pharma’s Halucenex almost doubles synthetic psilocybin supply
Creso Pharma’s (ASX: CPH) soon-to-be subsidiary Halucenex Life Sciences has almost doubled its synthetic psilocybin supply as it gears up for a clinical trial and other research and development. In a market where synthetic psilocybin is hard to secure, Halucenex has obtained a further 10g of the material – taking its total inventory to 22.3g. […]
Creso Pharma acquisition target Halucenex to test efficacy of synthetic liquid psilocybin for use in treatment-resistant PTSD
Creso Pharma’s (ASX: CPH) acquisition target Halucenex Life Sciences Inc has signed an agreement with Canadian pharmaceutical research firm Nucro-Technics to provide microbiology and chemistry test work for a salient delivery solution using synthetic psilocybin. The two companies will work together to test the stability and shelf life of psilocybin liquid formulations for use in […]
Creso Pharma’s Halucenex makes deal to create pure psilocybin amid softening regulations
As California moves to decriminalise psychedelics, Creso Pharma’s (ASX: CPH) soon-to-be subsidiary Halucenex Life Sciences has signed a letter of intent with Canadian listed Sixth Wave Innovations to work together on developing psilocybin separation technology for research and development. Sixth Wave has created a nanotechnology that uses molecularly imprinted polymers (MIPs) for imprinting, capturing and […]
Creso Pharma signs bilateral deal with South African skincare company to market cannabidoil products
Biotechnology company Creso Pharma (ASX: CPH) has signed a bilateral commercial agreement with South African skincare company Cannabis Queen to market and distribute its range of cannabidoil-based nutraceutical and tea products. Under the terms of the initial one-year deal, Cannabis Queen will market CannaDOL topical gels to treat arthritis and sports-related muscle injuries, as well […]